Former Pharmaceutical Company CEO Shkreli Indicted On Securities Fraud Charges

Mealey's (December 17, 2015, 2:34 PM EST) -- BROOKLYN, N.Y. — Federal authorities on Dec. 17 arrested former hedge fund manager and pharmaceutical company CEO Martin Shkreli for his alleged role in orchestrating a Ponzi scheme from 2009 to 2014 and unsealed an indictment in New York federal court charging him with seven counts of securities fraud, securities fraud conspiracy and wire fraud conspiracy (United States of America v. Martin Shkreli, No. 15-637, E.D. N.Y.).

(Indictment available. Document #57-160120-002X.)

Former Katten Muchin Rosenman LLP partner and outside counsel of pharmaceutical company Retrophin Inc. Evan...
To view the full article, register now.